Intermolecular Inc. (NYSE: IMI) getting new coverage from analysts.
JPMorgan Chase & Co. (NYSE:JPM) initiated coverage on Intermolecular Inc. (IMI). They placed an “Overweight” rating on the company.
Morgan Stanley (NYSE:MS) initiated coverage on Intermolecular Inc. (IMI). They placed an “overweight” rating on the company.
Needham & Company initiated coverage on Intermolecular Inc. (IMI). They placed a “Buy” rating and a price target of $13.00 on the company.
Barclays Capital (NYSE:BCS) initiated coverage on Intermolecular Inc. (IMI). They placed an “Equal Weight” rating on the company.
Pacific Crest initiated coverage on Intermolecular Inc. (IMI). They placed an “Outperform” rating on the company.
Thursday, January 5, 2012
Intermolecular Inc. (IMI) Gets New Coverage
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment